Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
According to Harvard Health, B12 deficiency can be sneaky and harmful often developing silently over years before symptoms become apparent
This page does not identify a published human intervention trial establishing safety, pharmacokinetics, dosing, weight-loss efficacy, metabolic benefit, anti-aging activity, or NAD + enhancement in people
Some patients experience mild injection site soreness or temporary flushing
Use within 3-4 weeks
Beyond that, lipo c with b12 may support metabolic health when combined with caloric restriction and exercise, but it does not directly eliminate fat on its own